MWO Medical is a unique technology built on 30 years of groundbreaking research of exercise as medicine from the Nobel-price-winning Faculty of Medicine at the Norwegian University of Science and Technology. The technology has been developed in-house by a Norwegian company, Myworkout AS, in cooperation with leading R&D partners since 2013.
Myworkout is a team of 28 FTEs with Professors of Medicine, Psychology, physiologists, MDs, technologists, designers, UX researchers, and marketers working to develop digital medicine with medical effects that can exceed conventional medicine.
The Myworkout team has carried out hundreds of international peer-reviewed publications in the field of exercise as medicine and several clinical studies showing the validity, clinical use, and effect of the technology for patients, fine-tuned through UX and iterated based on feedback from more than 130K users of the technology.
The unique and world-first technology distributes the medicine directly to the patient without needing support or gadgets other than the smartphone itself.
The same technology determines cardiorespiratory fitness with scientific precision, which, according to the American Heart Association, is the most crucial parameter for risk detection for disease and early death.
The clinical validation is documented and published in leading international medical journals. The technology and the medical basis for the app are approved by the Norwegian Directorate of Health and E-health as digitally supported exercise as medicine. MWO Medical technology and the medical basis for the first diagnoses are expected to be approved by MDR in the EU and FDA in the USA in 2024.
J. Helgerud, H. Haglo, J. Hoff. (2022) Prediction of VO2max From Submaximal Exercise Using the Smartphone Application Myworkout GO: Validation Study of a Digital Health Method. JMIRCardio 6: e38570.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389381/